What's new

Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 5, Status: Authorised

Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 5, Status: Authorised

Mar 31, 2025 - 12:48
 0
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 5, Status: Authorised
Human medicines European public assessment report (EPAR): Rukobia, fostemsavir, Date of authorisation: 04/02/2021, Revision: 5, Status: Authorised
Read More

Tags:

Previous Article

Vertical Aerospace adopts universal fast-charging standard to accelerate eVTOL d...

Next Article

Glasgow wholesaler JW Filshill strengthens sales team with appointment of Estell...

Related Posts

Human medicines European public assessment report (EPAR): Qoyvolma, ustekinumab, Status: Opinion

Human medicines European public assessment report (EPAR...

Mar 28, 2025  0

EMA Open Door Day, European Medicines Agency, Amsterdam, the Netherlands, from 9 May 2025, 09:45 (CEST) to 9 May 2025, 16:00 (CEST)

EMA Open Door Day, European Medicines Agency, Amsterdam...

Feb 18, 2025  0

EMEA-002734-PIP01-19-M01

EMEA-002734-PIP01-19-M01

Mar 25, 2025  0